Stemcentrx, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Stemcentrx, Inc. is a biotechnology research company located in South San Francisco, California. Founded in 2008, it integrates laboratory discovery with GMP manufacturing to accelerate moving from target discovery to clinical testing. The company's work centers on cancers by identifying cancer stem cells, uncovering novel targets, and designing and producing antibodies and antibody-drug conjugates. This approach spans early research through clinical investigation, with laboratories and manufacturing facilities described as state-of-the-art. The culture is portrayed as focused and collaborative, echoing the startup environment of the region. Its stated mission is to develop therapies that cure or substantially improve survival for cancer patients, reflecting a focus on strategies aimed at eradicating cancer stem cells that initiate and sustain tumors. In the biotechnology sector, Stemcentrx positions itself at the intersection of discovery and therapeutic development, aiming to translate scientific insight into patient-accessible treatments. The firm appears to target serious, potentially lethal cancers through its proprietary platforms and manufacturing capabilities. The company employs a small team, reflecting its status as a compact organization within the broader life sciences ecosystem of South San Francisco.